AIMT - Aimmune Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts77119
Avg. Estimate-1.04-0.96-3.66-1.8
Low Estimate-1.27-1.19-4.67-4.05
High Estimate-0.8-0.75-2.99-0.24
Year Ago EPS-0.87-1.01-3.97-3.66
Revenue EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts77119
Avg. Estimate3.29M8.1M51.77M194.59M
Low Estimate500k5.7M28.88M106.64M
High Estimate6.82M11.94M87M280.46M
Year Ago SalesN/AN/AN/A51.77M
Sales Growth (year/est)N/AN/AN/A275.90%
Earnings History3/30/20196/29/20199/29/201912/30/2019
EPS Est.-0.97-0.94-1.03-1.06
EPS Actual-0.87-1.01-1.03-1.06
Difference0.1-0.0700
Surprise %10.30%-7.40%0.00%0.00%
EPS TrendCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Current Estimate-1.04-0.96-3.66-1.8
7 Days Ago-1-0.95-3.63-1.79
30 Days Ago-0.96-0.88-3.56-1.62
60 Days Ago-0.92-0.85-3.54-1.58
90 Days Ago-0.92-0.85-3.43-1.17
EPS RevisionsCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days2143
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1111
Growth EstimatesAIMTIndustrySectorS&P 500
Current Qtr.-19.50%N/AN/A0.00
Next Qtr.5.00%N/AN/A0.08
Current Year7.80%N/AN/A0.01
Next Year50.80%N/AN/A0.15
Next 5 Years (per annum)34.60%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A